Tenon Medical Stock Today
| TNON Stock | USD 2.54 0.09 3.42% |
Performance0 of 100
| Odds Of DistressOver 85
|
Tenon Medical is selling at 2.54 as of the 25th of November 2024; that is 3.42 percent decrease since the beginning of the trading day. The stock's open price was 2.63. Tenon Medical has a very high chance of experiencing financial distress in the next few years of operation. It has also generated negative returns for investors over the last 90 days. Equity ratings for Tenon Medical are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 29th of February 2024 and ending today, the 25th of November 2024. Click here to learn more.
Business Domain Health Care Equipment & Services | IPO Date 27th of April 2022 | Category Healthcare | Classification Health Care |
Tenon Medical, Inc., a medical device company, develops surgical implant systems to optimize sacroiliac joint fixationfusion surgery and corresponding outcomes. The company was founded in 2012 and is based in Los Gatos, California. Tenon Medical operates under Medical Devices classification in the United States and is traded on NASDAQ Exchange. The company has 3.14 M outstanding shares of which 206.66 K shares are at this time shorted by private and institutional investors with about 0.11 trading days to cover. More on Tenon Medical
Moving against Tenon Stock
Follow Valuation Profit Patterns Odds of Bankruptcy
Check how we calculate scores
Tenon Stock Highlights
ESG Sustainability
Environmental | Governance | Social |
| President CEO | Steven Foster | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Business Concentration | Health Care Equipment & Supplies, Health Care Equipment & Services, Health Care, NASDAQ Composite, NASDAQ Health Care, Health Care, Health Care Equipment & Supplies, Medical Devices, Healthcare (View all Sectors) | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Average Analyst Recommendation | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Financial Strength
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Debt LevelsTenon Medical can leverage the use of borrowed funds to amplify returns from an investment. In general, analyzing the relationship between debt to total assets helps investors to understand Tenon Medical's financial leverage. It provides some insight into what part of Tenon Medical's total assets is financed by creditors.
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Tenon Medical (TNON) is traded on NASDAQ Exchange in USA. It is located in 104 Cooper Court, Los Gatos, CA, United States, 95032 and employs 21 people. Tenon Medical is listed under Health Care Equipment & Supplies category by Fama And French industry classification. The company currently falls under 'Nano-Cap' category with a current market capitalization of 7.97 M. Tenon Medical conducts business under Health Care Equipment & Supplies sector and is part of Health Care industry. The entity has 3.14 M outstanding shares of which 206.66 K shares are at this time shorted by private and institutional investors with about 0.11 trading days to cover.
Tenon Medical currently holds about 16.02 M in cash with (12.18 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 1.42.
Check Tenon Medical Probability Of Bankruptcy
Ownership AllocationAbout 96.51 % of Tenon Medical outstanding shares are held by general public with 1.7 (%) owned by insiders and only 1.8 % by institutional holders.
Check Tenon Ownership Details
Tenon Stock Institutional Holders
| Instituion | Recorded On | Shares | |
| Wells Fargo & Co | 2024-06-30 | 0.0 | |
| Qube Research & Technologies | 2024-06-30 | 0.0 | |
| Vanguard Group Inc | 2024-09-30 | 0.0 | |
| Geode Capital Management, Llc | 2024-09-30 | 0.0 | |
| Tmd Wealth Management, Llc | 2024-06-30 | 426.8 K | |
| Spectrum Asset Management Inc | 2024-06-30 | 80.2 K | |
| Tower Research Capital Llc | 2024-06-30 | 7.5 K | |
| Royal Bank Of Canada | 2024-06-30 | 1.7 K | |
| Bnp Paribas Arbitrage, Sa | 2024-06-30 | 191 | |
| Alphamark Advisors, Llc | 2024-09-30 | 50.0 | |
| Ubs Group Ag | 2024-06-30 | 33.0 |
Tenon Medical Historical Income Statement
Tenon Stock Against Markets
Tenon Medical Corporate Executives
Elected by the shareholders, the Tenon Medical's board of directors comprises two types of representatives: Tenon Medical inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Tenon. The board's role is to monitor Tenon Medical's management team and ensure that shareholders' interests are well served. Tenon Medical's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Tenon Medical's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Steven Dick | Executive CFO | Profile |
Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Tenon Medical. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in persons. To learn how to invest in Tenon Stock, please use our How to Invest in Tenon Medical guide.You can also try the Investing Opportunities module to build portfolios using our predefined set of ideas and optimize them against your investing preferences.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Tenon Medical. If investors know Tenon will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Tenon Medical listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share 287.92 | Revenue Per Share 9.442 | Quarterly Revenue Growth 0.213 | Return On Assets (1.10) | Return On Equity (15.99) |
The market value of Tenon Medical is measured differently than its book value, which is the value of Tenon that is recorded on the company's balance sheet. Investors also form their own opinion of Tenon Medical's value that differs from its market value or its book value, called intrinsic value, which is Tenon Medical's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Tenon Medical's market value can be influenced by many factors that don't directly affect Tenon Medical's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Tenon Medical's value and its price as these two are different measures arrived at by different means. Investors typically determine if Tenon Medical is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Tenon Medical's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.